The EGR2 gene provides instructions for making a protein called early growth response 2, which is part of the early growth response family of proteins.
These proteins bind to specific areas of DNA and help control the activity of particular genes.
On the basis of this action, the proteins are referred to as transcription factors.
The early growth response 2 protein activates several genes that are involved in the formation and maintenance of myelin, the fatty substance that covers and protects nerve cells.
Myelin promotes the efficient transmission of nerve impulses.
If myelin is lost (demyelination) or its structure is disrupted, the transmission of nerve impulses is impaired.
Mutations in the EGR2 gene can cause two forms of Charcot-Marie-Tooth disease, type 1D or type 4E (sometimes called congenital hypomyelinating neuropathy) or a severe form of type 1D (sometimes called Dejerine-Sottas syndrome) that begins during infancy or early childhood.
Applications:Suitable for use in Western Blot.
Other applications not tested.
Recommended Dilution:Western Blot: 2 ug/mlOptimal dilutions to be determined by the researcher.
Storage and Stability:May be stored at 4°C for short-term only.
For long-term storage and to avoid repeated freezing and thawing, add sterile glycerol (40-50%, aliquot and store at -20°C.
Aliquots are stable for at least 12 months at -20°C.
For maximum recovery of product, centrifuge the original vial after thawing and prior to removing the cap.
Further dilutions can be made in assay buffer.
仕様
Size：100ul
Host：rabbit
Source Antibody：human
Grade：Affinity Purified
Purity：Purified by immunoaffinity chromatography.
Form：Supplied as a liquid in 0.9 mg/ml Tris-glycine and 150mM NaCl.0, 0.09% sodium azide.
Specificity：This antibody is specific for EGR2. Reacts with human EGR2 protein. No other species have been tested.
Isotype：IgG
Calc Applications Abbrev：WB
Calc Crossreactivity：Hu Po
Immunogen：Synthetic peptide made to a portion of human EGR2 protein sequence within residues 200-300. [Swiss-Prot# P11161].
